- Trials with a EudraCT protocol (391)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
391 result(s) found for: Transplant rejection.
Displaying page 1 of 20.
EudraCT Number: 2008-007047-13 | Sponsor Protocol Number: TER_AFE2009 | Start Date*: 2009-04-27 | |||||||||||
Sponsor Name:OSPEDALE POLICLINICO S. MATTEO | |||||||||||||
Full Title: Prevention and treatment of kidney transplantation rejection by means of innovative therapeutic apheresis. | |||||||||||||
Medical condition: Patients waiting for first corpse kidney transplantation or re-transplantation, with PRA values > 50% | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-006729-15 | Sponsor Protocol Number: IGG-GIFA-001 | Start Date*: 2008-11-25 | |||||||||||
Sponsor Name:ISTITUTO GIANNINA GASLINI | |||||||||||||
Full Title: OPEN PILOT STUDY, TWO ARMS, WITH HISTORIC CONTROL, MULTICENTRIC TO EVALUATE SAFETY AND EFFICACY OF ASSOCIATION WITH EVEROLIMUS AND LOW DOSES OF CYCLOSPORIN AND STEROIDS AFTER INDUCTION WITH MONOCLO... | |||||||||||||
Medical condition: pediatric patient after kidney transplant | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-000864-16 | Sponsor Protocol Number: CRAD001AIT02 | Start Date*: 2005-04-12 | |||||||||||
Sponsor Name:NOVARTIS FARMA | |||||||||||||
Full Title: Multicenter, randomized, open-label trial to evaluate the safety, tolerability and efficacy of two regimens of Everolimus plus Neoral, given according different blood target levels, in de novo rena... | |||||||||||||
Medical condition: Prevention of rejection in adult renal transplant patients in combination with Neoral and corticosteroids | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-000782-35 | Sponsor Protocol Number: CERL080AIT06 | Start Date*: 2004-06-10 | |||||||||||
Sponsor Name:NOVARTIS FARMA | |||||||||||||
Full Title: EVALUATION OF THE QUALITY OF LIFE AND GASTROINTESTINAL SYMPTOMS AFTER CONVERSION TO MYFORTIC (ERL080) and CELLCEPT WITHDRAWAL IN MAINTENANCE RENAL TRANSPLANT RECIPIENTS TREATED WITH TACROLIMUS. | |||||||||||||
Medical condition: Prophylaxis of transplant rejection in adult patients receiving calcineurin inhibitors with / without corticosteroids after allogeneic renal transplants. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-003231-20 | Sponsor Protocol Number: BE-02-RG-186 | Start Date*: 2008-11-26 | |||||||||||
Sponsor Name:KULeuven | |||||||||||||
Full Title: Adherence Measurement in stable renal transplant patients following conversion form Prograft to advagraf | |||||||||||||
Medical condition: Renal transplant patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-005503-17 | Sponsor Protocol Number: 200710602 | Start Date*: 2011-03-31 | |||||||||||
Sponsor Name:Medizinische Hochschule Hannover | |||||||||||||
Full Title: Randomized multicenter double-blind study of phase III in patients after kidney transplantation with an acute cellular rejection with a tubulointerstinal component in kidney transplant with histolo... | |||||||||||||
Medical condition: It should be proved that additional treatment with Rituximab in patients with histologic proof of an acute cellular rejection with CD20+ lymphocytes is superior to a solitary therapy with Steroidbo... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-005604-14 | Sponsor Protocol Number: AIFA TX | Start Date*: 2006-12-19 | |||||||||||
Sponsor Name:IST. DI RICERCHE FARMACOLOG. M. NEGRI | |||||||||||||
Full Title: A randomized, prospective, multicenter trial to compare the effect on chronic allograft nephropathy prevention of mycophenolate mofetil versus azathioprine as the sole immunosuppressive therapy f... | |||||||||||||
Medical condition: kidney transplant | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-000889-22 | Sponsor Protocol Number: ICKTI08TX01 | Start Date*: 2008-11-11 | |||||||||||
Sponsor Name:Imperial College Healthcare NHS Trust | |||||||||||||
Full Title: A randomised controlled comparison of standard release Tacrolimus vs extended-release Tacrolimus as baseline maintenance monotherapy for kidney transplantation after induction with Campath 1-H. | |||||||||||||
Medical condition: Prevention of allograft rejection after renal transplantation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-012350-20 | Sponsor Protocol Number: MSC-KTx | Start Date*: 2008-01-14 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA "OSPEDALI RIUNITI DI BERGAMO" (A.O. DI RILIEVO NAZIONALE) | |||||||||||||
Full Title: MESENCHYMAL STEM CELLS UNDER BASILIXIMAB/ LOW DOSE RATG TO INDUCE RENAL TRANSPLANT TOLERANCE | |||||||||||||
Medical condition: Patients will be those receiving a living-related kidney transplant | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-000655-41 | Sponsor Protocol Number: CFTY720A2308 | Start Date*: 2005-02-10 | |||||||||||
Sponsor Name:Novartis Farmacéutica S.A | |||||||||||||
Full Title: A one-year, multicenter, open-label, feasibility study to evaluate the safety and the efficacy of FTY720 5mg introduction and CNI elimination in adult maintenance renal transplant reicpients mainta... | |||||||||||||
Medical condition: prevention of acute rejection in maintenance renal transplant recipients | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-006162-33 | Sponsor Protocol Number: ML 19835 | Start Date*: 2006-07-03 | |||||||||||
Sponsor Name:ROCHE | |||||||||||||
Full Title: Relationships between pharmacokinetic and pharmacodynamic strategies for assessment of the risks for acute rejection and side effects of mofetil mycophenolate | |||||||||||||
Medical condition: Kidney transplantation | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-002856-34 | Sponsor Protocol Number: LTx18-01 | Start Date*: 2019-03-01 | |||||||||||
Sponsor Name:Foundation for Liver research | |||||||||||||
Full Title: Modifying tacrolimus related toxicity after liver transplantation. A randomized controlled trial comparing Envarsus® and Advagraf® in de novo liver transplant recipients. | |||||||||||||
Medical condition: liver transplantation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-002330-38 | Sponsor Protocol Number: RituxiCAN-C4 | Start Date*: 2006-11-22 | |||||||||||
Sponsor Name:King's College London | |||||||||||||
Full Title: Randomised Trial of Anti-CD20 in C4d+ Chronic Allograft Nephropathy | |||||||||||||
Medical condition: Renal Transplant Rejection - chronic | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-000855-14 | Sponsor Protocol Number: 01-865-2005 | Start Date*: 2005-07-18 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI PADOVA | |||||||||||||
Full Title: Multicenter, not controlled, prospectic clinical phase IV study: safety and efficacy of an immunosuppressive regimen with Thymoglobuline and Rapamune in patients receiving a renal transplantation f... | |||||||||||||
Medical condition: Acute rejection prophylaxis after single-double kidney transplantation from marginal donors making use of a not nephrotoxic immunosuppressive regimen. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000441-12 | Sponsor Protocol Number: 0624-201 | Start Date*: 2012-09-21 | |||||||||||
Sponsor Name:VIROPHARMA Incorporated | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled pilot study to evaluate the safety and effect of Cinryze (C1 Esterase Inhibitor (Human)) for the treatment of acute antibody-mediated rejection in rec... | |||||||||||||
Medical condition: Acute Antibody Mediated Rejection (AMR) in kidney transplant patients | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-004958-63 | Sponsor Protocol Number: CFTY720 0125E1 | Start Date*: 2005-08-04 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A two-year extension to a one-year, multicenter, partially blinded, double-dummy, randomized study to evaluate the efficacy and safety of FTY720 combined with reduced-dose or full-dose Neoral and c... | |||||||||||||
Medical condition: Prophylaxis of kidney allograft rejection in de novo adult renal transplant recipients | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-002825-52 | Sponsor Protocol Number: CRAD001A2401T | Start Date*: 2014-04-03 | |||||||||||
Sponsor Name:Medizinische Hochschule Hannover | |||||||||||||
Full Title: Single-center, open-label, single-arm Phase IIa study in kidney transplant patients with acute T-cell-mediated rejection in renal transplant according to Banff criteria (class IA and IB) without (s... | |||||||||||||
Medical condition: Acute cellular rejection after kidney transplantation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-002090-21 | Sponsor Protocol Number: IM103177 | Start Date*: 2016-02-02 | |||||||||||
Sponsor Name:Bristol-Myers Squibb International Corporation | |||||||||||||
Full Title: Evaluation of Acute Rejection Rates in de novo Renal Transplant Recipients Following Thymoglobulin Induction, CNI-free, Nulojix (belatacept) -based Immunosuppression | |||||||||||||
Medical condition: Maintenance of renal transplant recipients. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-023746-67 | Sponsor Protocol Number: TRITON | Start Date*: 2011-06-14 | |||||||||||||||||||||
Sponsor Name:Dr Daniel Serón. Servicio de Nefrología. Hospital Universitario Vall d'Hebron | |||||||||||||||||||||||
Full Title: Tratamiento con inmunoglobulinas y rituximab en el rechazo crónico humoral en el trasplante renal: estudio multicéntrico, prospectivo, randomizado y controlado con placebo. Treatment with intraven... | |||||||||||||||||||||||
Medical condition: Trasplate renal con rechazo crónico humoral Renal transplant with chronic humoral rejection | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: ES (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-002914-20 | Sponsor Protocol Number: RRK3367 | Start Date*: 2007-09-20 | ||||||||||||||||
Sponsor Name:University Hospital Birmingham NHS Foundation Trust | ||||||||||||||||||
Full Title: Calcineurin Inhibitor Minimisation in Renal Transplant Recipients with Stable Allograft Function: A Prospective Randomised Controlled Trial | ||||||||||||||||||
Medical condition: Renal Transplantation | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
